The Lundquist Institute at Harbor-UCLA Medical Center in West Carson has snagged a major federal grant to study the causes of antibiotic-resistant infections. The institute announced last month that one of its principal investigators, Michael Yeaman, was awarded an $11.5 million grant from the National Institute of Allergy and Infectious Diseases.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial conducted in the first half of 2021 and co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Large International Trial Shows Strong Protection Against Severe COVID-19 with Antibody Combination miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial conducted in the first half of 2021 and co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
/PRNewswire/ The American Board of Medical Specialties (ABMS), the leading not-for-profit organization that oversees U.S. physician certification, will host.